APA (7th ed.) Citation

Zhang, S., Yang, Y., Zhang, L., Liu, Y., Guo, Z., Wu, J., . . . Zhang, W. (2024). Identification and Validation of a Prognostic Signature Based on Fibroblast Immune-related Genes to Predict the Prognosis and Therapeutic Response of renal clear cell carcinoma by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data. Journal of Cancer, 15(18), 5942. https://doi.org/10.7150/jca.100194

Chicago Style (17th ed.) Citation

Zhang, Shuwen, Yuqian Yang, Liyi Zhang, Yijiang Liu, Zihun Guo, Jiajun Wu, Weijun Zhou, Zhengdong Hong, and Wenxiong Zhang. "Identification and Validation of a Prognostic Signature Based on Fibroblast Immune-related Genes to Predict the Prognosis and Therapeutic Response of Renal Clear Cell Carcinoma by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data." Journal of Cancer 15, no. 18 (2024): 5942. https://doi.org/10.7150/jca.100194.

MLA (9th ed.) Citation

Zhang, Shuwen, et al. "Identification and Validation of a Prognostic Signature Based on Fibroblast Immune-related Genes to Predict the Prognosis and Therapeutic Response of Renal Clear Cell Carcinoma by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data." Journal of Cancer, vol. 15, no. 18, 2024, p. 5942, https://doi.org/10.7150/jca.100194.